Roivant Sciences (ROIV) Prepaid Assets (2021 - 2026)
Roivant Sciences (ROIV) posted Prepaid Assets of $105.3 million for Q1 2026, down 18.93% on a QoQ basis from $129.9 million in Q4 2025, and down 6.94% year-over-year from $113.2 million in Q1 2025.
Roivant Sciences (ROIV) Prepaid Assets (2021 - 2026) Analysis & Trends
Roivant Sciences' Prepaid Assets history runs 6 years deep, the most recent figure standing at $105.3 million for Q1 2026.
- Quarterly Prepaid Assets fell 6.94% year-over-year to $105.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $105.3 million (down 6.94% YoY) and the FY2026 annual result came in at $105.3 million, down 6.94% from the prior year.
- Prepaid Assets was $105.3 million for Q1 2026 at Roivant Sciences, down from $129.9 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $323.0 million in Q2 2024 and bottomed at $53.4 million in Q1 2022.
- A 5-year average of $103.1 million and a median of $93.3 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 399.53% — and 2025, when it slumped 65.14%.
- Roivant Sciences' Prepaid Assets stood at $69.5 million in 2022, then surged by 95.55% to $135.9 million in 2023, then slumped by 57.58% to $57.7 million in 2024, then soared by 125.32% to $129.9 million in 2025, then dropped by 18.93% to $105.3 million in 2026.
- Business Quant data shows ROIV's Prepaid Assets at $105.3 million in Q1 2026, $129.9 million in Q4 2025, and $125.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Roivant Sciences | 24.35 Bn | 25.12 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 105.32 Mn |
| Dec 31, 2025 | 129.91 Mn |
| Sep 30, 2025 | 125.81 Mn |
| Jun 30, 2025 | 112.60 Mn |
| Mar 31, 2025 | 113.17 Mn |
| Dec 31, 2024 | 57.66 Mn |
| Sep 30, 2024 | 54.84 Mn |
| Jun 30, 2024 | 322.99 Mn |
| Mar 31, 2024 | 80.61 Mn |
| Dec 31, 2023 | 135.92 Mn |
| Sep 30, 2023 | 60.72 Mn |
| Jun 30, 2023 | 64.66 Mn |
| Mar 31, 2023 | 60.83 Mn |
| Dec 31, 2022 | 69.51 Mn |
| Sep 30, 2022 | 111.85 Mn |
| Jun 30, 2022 | 93.27 Mn |
| Mar 31, 2022 | 53.37 Mn |
| Dec 31, 2021 | 70.33 Mn |
| Sep 30, 2021 | 55.56 Mn |
| Jun 30, 2021 | 58.17 Mn |